4 active not recruiting. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Active not recruiting 4 |
Follow Dermatitis, Atopic: new trials by email Literature Review of Dermatitis, Atopic trials Research Report on Dermatitis, Atopic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lebrikizumab in Moderate-to-severe Atopic Dermatitis lebrikizumab - Atopic Dermatitis | Phase 4 | Active not recruiting | Johann E Gudjonsson MD PhD | 48 | 2025-07-02 | 2026-09-15 |
| A Study of Long-term Effect of Dupilumab on Skin Barrier Function in Pediatric Participants With Atopic Dermatitis dupilumab - Dermatitis Atopic | Phase 4 | Active not recruiting | Sanofi | 48 | 2024-02-22 | 2026-04-13 |
| Bodewell Products for the Treatment of Atopic Dermatitis Bodewell Calming Cream - Atopic Dermatitis | Phase 4 | Active not recruiting | University of Alabama at Birmingham | 15 | 2023-11-01 | 2026-03-02 |
| DUPIlumab Dose REDUCtion in Patients With Controlled Atopic Eczema Dupilumab - Atopic Dermatitis, Atopic Dermatitis Eczema | Phase 4 | Active not recruiting | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 216 | 2023-08-14 | 2026-10-29 |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4) · Dermatitis (4) · Genetic Diseases, Inborn (4) · Hypersensitivity (4) · Hypersensitivity, Immediate (4) · Immune System Diseases (4) · Skin Diseases (4) · Skin Diseases, Eczematous (4) · Skin Diseases, Genetic (4) · Skin and Connective Tissue Diseases (4)
dupilumab (2) · lebrikizumab (1)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Johann E Gudjonsson MD PhD (1) · Sanofi (1) · University of Alabama at Birmingham (1)
United States (3) · Germany (1) · Netherlands (1) · Switzerland (1) · United Kingdom (1)
DirkJan Hijnen, MD PhD (1) · Johann E. Gudjonsson, MD, PhD (1) · Louise AA Gerbens, MD PhD (1) · Phyllis I Spuls, MD PhD (1) · Tiffany Mayo, MD (1)
2023 (1)